Suitable sample types
Notes
The following pathogens are identified utilising the BioFire Respiratory Panel: Adenovirus, Coronavirus (229E, HKU1, NL63, OC43, Sars-CoV-2), Human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A (including subtypes H1, H3 and H1-2009), Influenza B, Parainfluenza (1, 2, 3, 4), Respiratory Syncytial Virus, Bordatella parapertussis, Bordatella pertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae.
Patient requesting criteria: Only CCU immunocompromised or Specific requests by Microbiologist/Virologist will be tested on BioFire. All other extended respiratory requests will be processed using routine testing using the Hologic Fusion assay.
No repeat testing is performed within 14 days.
Results: are communicated electronically to Bed Management Teams and Infection Control.
Information Sharing: If your sample needs to be referred or a notifiable disease is detected from your sample, your details and sample may be shared with the UK Health Security Agency (UKHSA). This is a legal requirement. The UKHSA is sponsored by the Department of Health and Social Care.